In-House Standardization of Carba NP Test for Carbapenemase Detection in Gram Negative Bacteria

Similar documents
MHSAL Guidelines for the Prevention and Control of Antimicrobial Resistant Organisms (AROs) - Response to Questions

Detection of Carbapenem Resistant Enterobacteriacae from Clinical Isolates

Guidance on screening and confirmation of carbapenem resistant Enterobacteriacae (CRE) December 12, 2011

Screening and detection of carbapenemases

Discussion points CLSI M100 S19 Update. #1 format of tables has changed. #2 non susceptible category

Detecting CRE. what does one need to do?

NONFERMENTING GRAM NEGATIVE RODS. April Abbott Deaconess Health System Evansville, IN

Prevalence of Extended Spectrum -Lactamases In E.coli and Klebsiella spp. in a Tertiary Care Hospital

ALERT. Clinical microbiology considerations related to the emergence of. New Delhi metallo beta lactamases (NDM 1) and Klebsiella

Evaluation of Six Phenotypic Methods for the Detection of Carbapenemases in Gram-Negative Bacteria With Characterized Resistance Mechanisms

Insert for Kit 98006/98010/ KPC/Metallo-B-Lactamase Confirm Kit KPC+MBL detection Kit KPC/MBL and OXA-48 Confirm Kit REVISION: DBV0034J

Nature and Science 2017;15(10)

Rapid detection of carbapenemase-producing Enterobacteriaceae from blood cultures

Carbapenemases in Enterobacteriaceae: Prof P. Nordmann Bicêtre hospital, South-Paris Med School

Phenotypic Detection Methods of Carbapenemase Production in Enterobacteriaceae

ORIGINAL ARTICLE. Julie Creighton and Clare Tibbs. Canterbury Health Laboratories, Christchurch

β CARBA Test Rapid detection of carbapenemase-producing Enterobacteriaceae strains Contents 1. INTENDED USE

Laboratory CLSI M100-S18 update. Paul D. Fey, Ph.D. Associate Professor/Associate Director Josh Rowland, M.T. (ASCP) State Training Coordinator

Determining the Optimal Carbapenem MIC that Distinguishes Carbapenemase-Producing

Detecting Carbapenemase-Producing Enterobacteriaceae: why isn t there a single best method?

β- Lactamase Gene carrying Klebsiella pneumoniae and its Clinical Implication

Impact of the isolation medium for detection of carbapenemase-producing Enterobacteriaceae using an updated version of the Carba NP test

Public Health Surveillance for Multi Drug Resistant Organisms in Orange County

Screening of Carbapenem Resistant Enterobacteriaceae among Nosocomial Isolates: A Study from South India

Detection of NDM-1, VIM-1, KPC, OXA-48, and OXA-162 carbapenemases by MALDI- TOF mass spectrometry

North Carolina CRE Laboratory Task Force

Incidence of metallo beta lactamase producing Pseudomonas aeruginosa in ICU patients

SSRG International Journal of Medical Science (SSRG-IJMS) volume 2 Issue 4 April 2015

Evaluation of CHROMagar msupercarba for the detection of carbapenemaseproducing Gram-negative organisms

Emergence of non-kpc carbapenemases: NDM and more

Carbapenem Disks on MacConkey agar as screening methods for the detection of. Carbapenem-Resistant Gram negative rods in stools.

EVALUATION OF METHODS FOR AMPC β-lactamase IN GRAM NEGATIVE CLINICAL ISOLATES FROM TERTIARY CARE HOSPITALS

Phenotypic detection of ESBLs and carbapenemases

Sensitive and specific Modified Hodge Test for KPC and metallo-beta-lactamase

Prevalence of Carbapenem Resistance in Gram Negative Bacilli Isolates and Their Antimicrobial Susceptibility Pattern

Regional Emergence of VIM producing carbapenem resistant Pseudomonas aeruginosa (VIM CRPA)

Surveillance of antimicrobial susceptibility of Enterobacteriaceae pathogens isolated from intensive care units and surgical units in Russia

Differentiation of Carbapenemase producing Enterobacteriaceae by Triple disc Test

Carbapenems and Enterobacteriaceae

2612 Page. *Yusuf, I 1., Rabiu A.T 1., Haruna, M 2. and Abdullahi, S. A 3. Phone:

Laboratory testing for carbapenems resistant Enterobacteriacae (CRE)

Enterobacteriaceae with acquired carbapenemases, 2016

Rapid detection of carbapenemase-producing Pseudomonas spp.

Multidrug-resistant organisms are a major public health

Original Article Clinical Microbiology

Recommendations for the Management of Carbapenem- Resistant Enterobacteriaceae (CRE) in Acute and Long-term Acute Care Hospitals

Received 31 January 2011/Returned for modification 2 March 2011/Accepted 15 March 2011

Enterobacteriaceae with acquired carbapenemases, 2015

CRO and CPE: Epidemiology and diagnostic tests

Rapid identification of emerging resistance in Gram negatives. Prof. Patrice Nordmann

Detection of carbapenemases in Enterobacteriaceae: a challenge for diagnostic microbiological laboratories

Toolkit for the Management of Carbapenemase Producing Organisms (CPO)

Educational Workshops 2016

HOSPITAL EPIDEMOLOGY AND INFECTION CONTROL: STANDARD AND TRANSMISSION-BASED ISOLATION

JMSCR Vol 05 Issue 03 Page March 2017

The role of an AMR reference laboratory

Standardisation of testing for Carbapenemase Producing Organisms (CPO) in Scotland

Overcoming the PosESBLities of Enterobacteriaceae Resistance

Infectious Disease Testing. UriSelect 4 Medium. Direct Identification Visibly Reliable

Detecting carbapenemases in Enterobacteriaceae

Sensitivity of Surveillance Testing for Multidrug-Resistant Gram-Negative Bacteria in the

Validating a selection method for. H. Hasman, Y. Agersø, C. Svendsen, H. Nielsen, N.S. Jensen, B. Guerra, Aarestrup, FM

Point Prevalence Survey for Screening of Carbapeneme Resistant Enterobacteriaceae in ICU Patients using CDC Protocol and Chromogenic Agar

#Corresponding author: Pathology Department, Singapore General Hospital, 20 College. Road, Academia, Level 7, Diagnostics Tower, , Singapore

Revised AAC Version 2» New-Data Letter to the Editor ACCEPTED. Plasmid-Mediated Carbapenem-Hydrolyzing β-lactamase KPC-2 in

Journal of Infectious Diseases and

Carbapenemase-producing Enterobacteriaceae

High Incidence of Multidrug Resistant Pseudomonas aeruginosa Isolated from Infected Burn Wounds in a Tertiary Hospital

Comparision of Antibiotic Susceptibility Testing As Per CLSI and Eucast Guidelines for Gram Negative Bacilli

AAC Accepts, published online ahead of print on 13 October 2008 Antimicrob. Agents Chemother. doi: /aac

Resistance to Polymyxins in France

International Journal of Scientific & Engineering Research, Volume 7, Issue 8, August ISSN

Carbapenem-resistant Escherichia coli and Klebsiella pneumoniae in Taiwan

Abstract. Introduction. Editor: R. Canton

CARBAPENEMASE PRODUCING ENTEROBACTERIACEAE

Use of Faropenem as an Indicator of Carbapenemase Activity

Research Article PhenotypicDetectionofMetallo-β-Lactamase in Imipenem-Resistant Pseudomonas aeruginosa

Global Epidemiology of Carbapenem- Resistant Enterobacteriaceae (CRE)

Appendix B: Provincial Case Definitions for Reportable Diseases

Affinity of Doripenem and Comparators to Penicillin-Binding Proteins in Escherichia coli and ACCEPTED

CRE Laboratory Detection & Recap of ARO Consensus Conference

Navigating Through Current and Emerging Issues in Outbreaks

Development of a phenotypic method for fecal carriage detection of OXA-48-producing

CHAPTER 8 ANTIBACTERIAL ACTIVITY OF THE CRUDE ETHANOLIC EXTRACT AND THE ISOLATED COMPOUNDS FROM THE STEM OF COSTUS IGNEUS

International transfer of NDM-1-producing Klebsiella. pneumoniae from Iraq to France

National Center for Emerging and Zoonotic Infectious Diseases The Biggest Antibiotic Resistance Threats

Scottish Microbiology and Virology Network. Carbapenemase producers: screening and the new Scottish AMR Satellite Reference Laboratory Service

New Mechanisms of Antimicrobial Resistance and Methods for Carbapenemase Detection

In Vitro Susceptibility Pattern of Cephalosporin- Resistant Gram-Negative Bacteria

Prevalence of ESBL producing enterobacteriaceae in diabetic foot ulcers

Positive for carbapenemase production by a phenotypic method

Spread of carbapenems resistant Enterobacteriaceae in South Africa; report from National Antimicrobial Resistance Reference Laboratory

320 MBIO Microbial Diagnosis. Aljawharah F. Alabbad Noorah A. Alkubaisi 2017

Emergence of Klebsiella pneumoniae ST258 with KPC-2 in Hong Kong. Title. Ho, PL; Tse, CWS; Lai, EL; Lo, WU; Chow, KH

ST11 KPC-2 Klebsiella pneumoniae detected in Taiwan

10/4/16. mcr-1. Emerging Resistance Updates. Objectives. National Center for Emerging and Zoonotic Infectious Diseases. Alex Kallen, MD, MPH, FACP

Rapid identification and resistance assessment: The future is mass spectrometry

AMPC BETA LACTAMASES AMONG GRAM NEGATIVE CLINICAL ISOLATES FROM A TERTIARY HOSPITAL, SOUTH INDIA. Mohamudha Parveen R., Harish B.N., Parija S.C.

False susceptibility of antibitoics to carbapenemase producers and means to overcome

Transcription:

International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 7 Number 01 (2018) Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2018.701.342 In-House Standardization of Carba NP Test for Carbapenemase Detection in Gram Negative Bacteria V. Mangayarkarasi *, Stephen Pradeep Moses, S.R. Swarna, K. Kalaiselvi and S. Shaweez Fathima Department of Microbiology, SRM Medical College Hospital and Research Centre, Kattankulathur-603203, Chennai, India *Corresponding author A B S T R A C T K e y w o r d s Carba NP test, Modified Hodge test, Epsilometer test, Carbapenem resistance, Antibiotic susceptibility testing Article Info Accepted: 20 December 2017 Available Online: 10 January 2018 This study was done to evaluate the performance of Carba NP test for the detection of carbapenemase producing Gram negative bacilli. In total, 330 Gram negative bacilli isolates were subjected to Antibiotic Susceptibility Testing, Epsilometer test, Modified Hodge test with meropenem to determine the presence of resistance among carbapenem group of drugs. 44/ 330(13.3%) showed resistance pattern. The 44 resistant isolates were then subjected to the Carba NP test and incubated at 37 C and results were read after 2 hours. According to the principle of Carba NP test there was a color change in all 44 isolates indicating a sensitivity of 100%. Overall, the Carba NP test is a useful tool for rapid detection of carbapenemase activity. Introduction Carbapenem drugs are a group of β-lactam antibiotics used in the treatment of infections caused by extended spectrum beta-lactamases (ESBL) producing gram negative bacteria (GNB) and several serious bacterial infections like meningitis, nosocomial pneumonia, nosocomial sinusitis and sepsis. The emergence of multidrug resistance is increasing at an alarming rate among a variety of bacterial species, causing both community acquired and nosocomial infections (Taneja et al., 2015). Over the past decade, the emergence of carbapenem resistant Enterobacteriaceae (CRE) has become a formidable threat to public health. The prevalence of CRE, according to some institutions in epidemic area, varies between 24.7% and 29.8%. (Xu et al., 2014) Indian single center studies overall report a prevalence of carbapenem resistance in up to 12-15% of Enterobacteriaceae. Resistance may be associated with hydrolysis of β lactam ring, an over expression of β lactactamase with no carbapenemase activity or an expression of carbapenemase. (Porwal et al., 2014) Various carbapenemases have been 2876

reported in Enterobacteriaceae such as the following types: Klebsiella pneumonia carbapenemase (KPC; Ambler class A); Verona integron encoded encodedmetallo β lactamase (VIM), imipenemase (IMI), New Delhi metallo β lactamase (NMD) (all Ambler class B), and oxacillinase-48 (OXA-48; Ambler class D) (Nordmann et al., 2011) Potential carbapenemase producers are detected by antibiotic susceptibility testing and phenotypic methods such as Modified Hodge test, these tests are not highly sensitive and specific, hence a newer and rapid method of detecting resistance is needed. A simple rapid test (Carba NP) was developed to identify the hydrolysis of the β lactam ring of a carbapenem. (Tijet, 2013) This study was done to evaluate the Carba NP test for the detection and screening of carbapenemase producing bacteria in comparison to phenotypic methods such as antibiotic susceptibility testing, epsilometer MIC test and Modified Hodge test. Materials and Methods The study was conducted at a tertiary care hospital in Tamil Nadu, India. Ethical clearance was obtained. Bacterial isolates A total of 330 isolates of Gram negative bacilli was obtained from various clinical samples (e.g. blood, pus, urine, etc.) of hospitalized patients admitted in the hospital for various infections over a period of 1 year from January 2016 to December 2016. Consent forms were obtained from the patients. The isolates were subcultured onto nutrient agar, blood agar and MacConkey agar and subjected to routine biochemical tests for its identification. Of the 330 isolates collected, 148(45%) were identified as Escherichia coli, 58(18%) identified as Pseudomonas spp., 54(16%) identified as Klebsiella pneumoniae, 34(10%) identified as Acinetobacter spp., 2877 24(7%) identified as Citrobacter spp. and 12(4%) identified as Proteus spp (Fig. 1) and (Fig. 2). Of the various clinical samples urine was the highest collected, followed by sputum and pus (Fig. 3). Antimicrobial susceptibility The isolates were inoculated in peptone water and incubated at 37 C for 30 minutes. It was then compared with 0.5 McFarland s standard, from peptone water the isolates were then streaked unto Mueller Hinton agar by lawn streaking method. The following antibiotics ertapenem (10μg), imipenem (10 μg) and meropenem (10 μg) from HI-Media Laboratories, BD Diagnostics Pvt Ltd, India were placed incubated for 18-24 hours. The readings were recorded according to Clinical and Laboratory Standards Institute (CLSI) 2016. Of the 330 isolates tested, 44 showed a resistance to one or more carbapenem drugs. Modified Hodge test The 330 isolates were subjected to Modified Hodge Test for detection of carbapenemase according to Center for Disease Control and Prevention (CDC). An overnight culture suspension of Klebsiella pneumonia ATCC BAA-1705 adjusted to 0.5 McFarland standard was inoculated using a sterile cotton swab on the surface of a Mueller Hinton agar (MHA) (HI-MEDIA, Mumbai, India). After drying, 10 μg meropenem disk (HI-MEDIA, Mumbai, India) was placed at the center of the plate and the test strain was streaked from the edge of the disk to the periphery of the plate in four different directions. The plate was incubated at 37 C for 18-24 hours. The presence of a cloverleaf shaped zone of inhibition due to carbapenemase production by the test strain was considered as positive. Out of 330 isolates tested 44 showed positive.

Epsilometer test The test strain was inoculated in peptone water for 30 minutes and compared with McFarlands standard 0.5. It was then streaked unto Mueller Hinton agar (MHA) (HI- MEDIA, Mumbai, India) with a sterile cotton swab by lawn culture streaking. MIC E strips of meropenem and ertapenem (HI-MEDIA, Mumbai, India) were placed separately and incubated at 37 C for 24 hours. Carba NP test Carba NP test was evaluated on those isolates that showed resistance in disk diffusion method to imipenem, meropenem, ertapenem (or) all 3 drugs. One modification was made, Imipenem Cilastatin instead of Imipenem Monohydrate was used in this study. (Abdel Ghani et al., 2015) One loopful (10 μl) of the tested strain directly recovered from the antibiogram plate was resuspended in a Tris- HCl 20 mmol/l lysis buffer, vortexed for 1 minute and further incubated at room temperature for 30 minutes. The bacterial suspension was then centrifuged at 10,000 g at room temperature for 5 minutes. 30μL of the supernatant bacterial suspension was mixed in a 96-well tray with 100 μl of a 1-mL solution made of 3 mg of Imipenem Cilastatin, ph 7.8, phenol red solution, and 0.1 mmol/l ZnSO 4. The phenol red solution was prepared by mixing 2 ml of a phenol red solution 0.5% (wt/vol) with 16.6 ml of distilled water. The ph value was then adjusted to 7.8 by adding drops of 1 N NaOH. A mixture of the phenol red solution and the enzymatic suspension being tested was placed in one well of the 96 well microtitre plate, to the next well an uninoculated solution was added and to the next a positive quality control of Klebsiella pneumonia ATCC BAA-1705 was used. The microtitre plate was then incubated at 37 C for 2 hours and results read. Results and Discussion Out of 330 Gram negative bacilli isolates obtained, 44 isolates showed resistance in disk diffusion method, epsilometer MIC test and Modified Hodge test. These 44 isolates were then subjected to Carba NP test and all 44 showed a positive reaction indicating presence of carbapenemase enzymes. Our study showed a prevalence of 13.3% (44/330) carbapenem resistant Enterobacteriaceae which was higher comparing to a study done in Chennai, India (Kumarasamy et al., 2010). There was a similarity in prevalence for carbapenem resistant Enterobacteriaceae when compared to a study done in Mumbai, India. Urine samples showed the highest percentage similar to the same study done (Nair, 2013). The rapid Carba NP test was a much simpler test to be performed in comparison to the phenotypic methods. It is inexpensive, rapid, reproducible, and highly sensitive and specific and thus eliminates the need for using other techniques to identify carbapenemase producers that are time-consuming and less sensitive or specific. The Carba NP test can efficiently indicate the strains to be further tested by PCR or submitted to sequencing for a detailed identification of the carbapenemase genes, the test could be used in low-income countries that are large reservoirs for carbapenemase producers. (Nordmann Patrice et al., 2012) Another study on 244 carbapenemase and non carbapenemase producing Enterobacteriaceae and Pseudomonas aeruginosa isolates showed a sensitivity and specificity of 80% and 77.3%, respectively by increasing the bacterial extract (Tijet, 2013). In our study there was a sensitivity and specificity of 100%. Mitra et al., reported that the Carba NP test performed poorly in detecting OXA-48 carbapenemases and needs to be further evaluated as OXA- 48/OXA-181 strains have been found widespread among Indian subcontinent. (Shetty, 2015) 2878

Fig.1 Distribution of Gram Negative Bacilli (n=330). The chart shows the various organisms isolated from various clinical samples. E. coli was isolated the most Fig.2 Distribution of various samples collected. Urine samples were collected the most 2879

Fig.3 Distribution of carbapenem resistant Gram Negative Bacilli (n=44). E. coli isolates showed the maximum resistance A comparison study between modified Hodge test and Carba NP test done by Bayramoğlu G et al., showed that the Carba NP test had a sensitivity of 93.9% to that of modified hodge test 90% concluding that the Carba NP test had a higher sensitivity, more reliant and non-time consuming as compared to modified hodge test. (Gülçin, 2016) concluded in this study that the Carba NP test detected all carbapenemase producers regardless of the type of the carbapenemase and of their mucoid phenotype (overall, there was 100% sensitivity and 100% specificity for carbapenemase producers, including OXA-48 producers, in a comparison with PCR results) by using 1.5ml eppendorf tubes instead of 96 well mictotitre plate. (Dortet et al., 2014) mentioned a sensitivity rate of 88% sensitivity he further mentioned that the sensitivity rate increases if the bacterial load from the isolate was more, in our study one standard loop size (10 μg) was enough to confirm resistance. (Osterblad et al., 2014) confirmed a sensitivity of 100%, similar in our study, when compared with modified hodgetest 98%, specificity of Carba NP test showed a higher significance of 100% to that of modified hodge test 80%, thus further strengthening the effectiveness of Carba NP test as a tool for detection (Vasoo et al., 2013). The rapid Carba NP test is an easy screening method for carbapenemase producing bacteria and holds a higher sensitivity rate and cost effective than that of the phenotypic methods employed for detection of carbapenemase production. This test can be implicated across for rapid screening and detection of carbapenemase producing bacteria and can help in early identification to prevent cross resistance to other patients by isolation of those resistant. Further evaluation of the Carba NP test can be done with PCR studies. Acknowledgement We thank SRM University for their constant support and for providing the fund necessary for completion of the project. 2880

We also thank the Hospital and Department of Microbiology for their support and cooperation. References Abdel Ghani, et al., Comparison of the Carba NP, Modified Carba NP, and Updated Rosco Neo-Rapid Carb Kit Tests for Carbapenemase Detection. Journal of Clinical Microbiology, 2015; 53(11), pp. 3539-3542. Dortet, L., et al., "Further Proofs of Concept for the Carba NP Test". Antimicrobial Agents and Chemotherapy 2014; 58, 1269-1269. Gülçin. "Comparison of the Modified Hodge Test and the Carba NP Test for Detection of Carbapenemases in Enterobacteriaceae Isolates". Mikrobiyoloji Bulteni 2016; 50, 1-10. Kumarasamy, K., et al., Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis. 2010; Sep; 10, 597 602. Nair, P. Prevalence of carbapenem resistant Enterobacteriaceae from a tertiary care hospital in Mumbai, India. Journal of Microbiology and Infectious Diseases, 2013; 03(04), pp.207-210. Nordmann Patrice et al., "Rapid Detection of Carbapenemase- Producing Enterobacteriaceae". Emerging Infectious Diseases 2012; 18, 1503-1507. Nordmann, P., et al., Global Spread of Carbapenemase- producing Enterobacteriaceae. Emerging Infectious Diseases 2011; 17, 1791-1798. Osterblad, M., et al., Evaluation of the Carba NP Test for Carbapenemase Detection. Antimicrobial Agents and Chemotherapy. 2014; 58, 7553-7556. Porwal, R., et al., Carbapenem resistant Gramnegative bacteremia in an Indian intensive care unit: A review of the clinical profile and treatment outcome of 50 patients. Indian Journal of Critical Care Medicine, 2014; 18(11), p.820. Shetty, A., "Evaluation of Carba NP Test for Rapid Detection of Carbapenemase Producing Enterobacteriaceae". Indian Journal of Medical Microbiology 2015; 33, 603. Taneja, N., et al., Occurrence of blandm-1 & absence of blakpcgenes encoding carbapenem resistance in uropathogens from a tertiary care centre from north India. Indian Journal of Medical Research, 2015; 142, 336. Tijet, N., "Evaluation of the Carba NP Test for Rapid Detection of Carbapenemase- Producing Enterobacteriaceae and Pseudomonas Aeruginosa". Antimicrobial Agents and Chemotherapy 2013; 57, 4578-4580 Vasoo, S., et al., Comparison of a Novel, Rapid Chromogenic Biochemical Assay, the Carba NP Test, with the Modified Hodge Test for Detection of Carbapenemase- Producing Gram-Negative Bacilli. Journal of Clinical Microbiology 2013; 51, 3097-3101 Xu, Y., et al., Epidemiology of carbapenem resistant Enterobacteriaceae (CRE) during 2000-2012 in Asia. Journal of Thoracic Disease 2014; 7, 376-385. How to cite this article: Mangayarkarasi, V., Stephen Pradeep Moses, S.R. Swarna, K. Kalaiselvi and Shaweez Fathima, S. 2018. In-House Standardization of Carba NP Test for Carbapenemase Detection in Gram Negative Bacteria. Int.J.Curr.Microbiol.App.Sci. 7(01): 2876-2881. doi: https://doi.org/10.20546/ijcmas.2018.701.342 2881